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Oral mucositis is one of the common side effects of chemotherapy treatment with potentially severe implications. Despite several
treatment approaches by conventional and complementary western medicine, the therapeutic outcome is often not satisfactory.
Traditional Chinese Medicine (TCM) offers empirical herbal formulas for the treatment of oral ulceration which are used
in adaptation to chemotherapy-induced mucositis. While standard concepts for TCM treatment do not exist and acceptance
by conventional oncologists is still low, we conducted a review to examine the evidence of Chinese herbal treatment in oral
mucositis. Eighteen relevant studies on 4 single herbs, 2 combinations of 2 herbs, and 11 multiherbal prescriptions involving 3 or
more compounds were included. Corresponding molecular mechanisms were investigated. The knowledge about detailed herbal
mechanisms, especially in multi-herbal prescriptions is still limited.The quality of clinical trials needs further improvement. Meta-
analysis on the existent database is not possible but molecular findings on Chinese medicinal herbs indicate that further research
is still promising for the treatment of chemotherapy-induced oral mucositis.
1. Introduction
Oral mucositis is one of the most common side effects
of chemotherapy treatment with potentially severe implica-
tions. According to the American National Cancer Institute,
ulcerative oral mucositis occurs in approximately 40% of
patients receiving standard-dose chemotherapy [1]. Medical
interventions are required in about 50% of these patients,
including changes of medication or chemotherapy dose
reduction. Severe mucositis symptoms occur in up to 80% in
high dose chemotherapy treatments of leukaemia or in stem
cell transplant regimens [1].
Mucosal damages may be induced for example, by
antimetabolites such as methotrexate, 5-fluorouracil, anthra-
cyclines such as doxorubicin and bleomycin, alkylating anti-
neoplastic agents such as cyclophosphamide and busulfan,
taxanes and the platinum complexes, including cisplatin and
carboplatin [1, 2]. All of them may have possible toxic effects
on rapidly dividing mucosal cells, partly related to drug
secretion in the saliva. Saliva volume and consistence as
well as the oral microbial flora may be altered, affecting the
mucosal metabolism [3]. Several molecular mechanisms are
involved in the pathogenesis of mucositis, such as oxidation
and apoptosismediated by nitric oxide (NO), cyclooxygenase
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(COX), protein kinases, cytokines, and nuclear factors [4].
The research field involves also genetic-based risk factors
[5]. Epigenetic changes of DNA methylation are discussed
as being responsible for inflammatorial precancerous condi-
tions [6]. A cancer diagnosis itself may lead to posttraumatic
stress disorder (PTSD), causing depression and anxiety as
well as an increased level of biomarker expression, such
as interleukin-6 (IL-6), tumor necrosis factor-𝛼 (TNF-𝛼),
cortisol, and high-reactive sensitive C-reactive protein. The
incidence of oral ulceration was associated with the level of
PTSD. These effects were observed to be significantly higher
in malignant than in benign diagnosed breast tumor patients
[7].
Typical manifestations of oral mucositis are soreness,
edema, erythema, ulcerations, bleeding, pain, difficulties in
swallowing and possible alteration of taste, and they may
severely affect the patient’s quality of life. Impaired nutrition
and complications by viral, bacterial, or mycotic infections
may additionally increase the risk of anticancer treatment
delay [8]. Mucositis grading is based on clinical aspects and
the nutritional state, as seen in Table 1. Grades III and IV are
considered as severe mucositis [9, 10] and in more than one-
third of these patients the next chemotherapy cycle needs to
be delayed leading to a possible deterioration of treatment
[11].
When uncomplicated by infections, mucositis may be
self-limiting in about 2 to 4 weeks [1]. Mucosal damages
and local factors such as periodontitis and suboptimal oral
hygiene increase the risk of infections. Systemic exacerbation
is facilitated by the commonly decreased immunological
status [12, 13]. Consequences are an increased mortality risk
as well as a prolonged hospitalisation, including the necessity
of fluid replacement and parenteral nutrition, causing an
increase of costs [9].
1.1. Preventive and Treatment Methods by Conventional
Medicine. The detailed guidelines for prevention and treat-
ment of mucositis are depending on the chemotherapy
regimens used in each case. General prevention instructions
include prior dental examinations and treatment and optimal
oral care [10, 16], as well as avoidance of spicy, hard and hot
foods and saline-peroxide mouthwashes [16].
There are numerous western experimental preventive
and therapeutical interventions for oral mucositis. Updated
clinical practice guidelines for the prevention and treatment
of mucositis were published by the Mucositis Study Section
of the Multinational Association of Supportive Care in
Cancer and the International Society for Oral Oncology
(MASCC/ISOO) in 2007 [10], suggesting the use of ker-
atinocyte growth factor-1 (KGF-1) for preventing mucositis
in high-dose chemotherapy regimens. Cryotherapy was sug-
gested formelphalan, 5-fluorouracil, and etidronate. Systemic
glutamine was not recommended because of severe toxicity.
Mouthwashing with granulocyte-macrophage-colony stim-
ulating factor (GM-CSF) did not show consistent effect.
Updated results are frequently published by MASCC/ISOO
[17]. According to a Cochrane review from 2010, nine
interventions for prevention and treatment of mucositis
showed statistical benefit: allopurinol, amifostine, cryother-
apy, intravenous glutamine, honey, KGF-1, laser, aloe vera,
and polymixin/tobramycin/amphotericin (PTA) antibiotic
pastille or paste compared to either placebo or no treatment
[18]. The updated Cochrane review, published in February
2013, came to the conclusion that cryotherapy and ker-
atinocyte growth factor had some benefits in preventing
mucositis and sucralfate showed effects in reducing the
severity of mucositis. Aloe vera, amifostine, granulocyte
growth factor, honey, laser, and PTA did not show consistent
effects [19].
Even concerning the progress achieved during the last
years, chemotherapy-induced oral mucositis continues to be
a challenge for a positive cancer treatment outcome [2, 18,
19]. The development of further treatment options for oral
mucositis remains an important research objective.
1.2. Complementary Medicine with Western Herbs. In west-
ern complementary medicine several herbal treatment
approaches are existent, including Salvia officinalis, Camo-
millamatriciana, Calendula officinalis, Hamamelis virginiana,
Tormentilla rhizome, Commiphora molmol, Rhataniae radix,
Myrtilli fructus, Althaea, Malva, Cetraria islandica, Linum
usitatissimum, Caryophylli flos, Hippophea rhamnoides, Aloe
vera, Carica papaya, Centaurii herba, Gentianae radix,
Menyanthis folium, Eriodictyon crassifolium, Oleum olivae,
and Citrus limon. They are applied as single infusions for
gargling or topical application [2]. Of these, Salvia officinalis,
Chammomilla matriciana, Aloe vera, and Gentianae radix
have also been used in the tradition of TCM.
Up to 80% of cancer patients use some kinds of Com-
plementary and Alternative Medicine (CAM) therapies to
support their conventional cancer treatments [20, 21]. Herbal
treatment is the most frequently used CAM therapy and
many of the used herbs originate from TCM [22, 23]. TCM
offers empirical herbal formulas for treatingmouth ulcers and
stomatitis which have frequently been used in complemen-
tary treatment of oral mucositis in the last decades, but the
evidence of these therapies is unclear. While standard con-
cepts for this kind of treatment do not exist and acceptance
by conventional oncologists is still low, we conducted this
review to critically examine the evidence of Chinese herbal
treatment in oral mucositis.
2. Methods
2.1. Objective. The objective of this article is to examine the
role of Chinese herbal medicine approaches to oral mucositis
in search of adjuvant treatment options for minimizing a
painful and risky side effect of chemotherapy as a potential
cooperation of western and Chinese medicine.
2.2. Search Strategy and Selection Criteria. Electronic
searches of PubMed, MEDLINE via OVID, EMBASE via
OVID, Cochrane Database, CNKI and reference lists of
relevant articles were undertaken. The mesh-terms used
were chemotherapy, chemotherapy-induced, oral ulcer,
mouth ulcer, oral mucositis, stomatitis, Chinese herbal
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Table 1: WHO oral toxicity scale [14, 15].
Grade 0 Grade I Grade II Grade III Grade IV
(None) (Mild) (Moderate) (Severe) (Life-threatening)
None Oral soreness, erythema Oral erythema, ulcers, solid diet tolerated Oral ulcers, liquid diet only Oral alimentation impossible
medicine, medicinal herbs, Chinese herbs, traditional
Chinese medicine, antioxidant, anti-inflammatory. All
interventional clinical trials concerning chemotherapy-
induced oral mucositis treated by Chinese herbal medicine
that offered an English or Chinese abstract were reviewed.
Articles investigating herbal or animal products used in
the tradition of Chinese medicine were included. Articles
investigating radiochemotherapy-induced oral mucositis
were excluded, unless the chemotherapy-related results were
separately processed.
2.3. Data Analysis. Nometa-analysis was effected since there
were reservations with regard to the high risk of bias due to
inadequate study designs and a diversity of herbal formulas.
We limited the discussion to the comparison of single herbs
and herbal formulas and to the quality of studies which have
to date been set up with regard to this topic.
3. Results
A total of 686 articles were retrieved from electronic searches
and from examination of reference lists of clinical and review
articles. After screening titles and/or abstracts, 632 articles
were excluded since the focus was either on an intervention
rather than on oral mucositis and Chinese herbal treatment
or they were duplicated studies or not relevant. From a total
of 54 articles which were retrieved for detailed evaluation, 18
studies representing 1,476 patients met the selection criteria
and were included in the review, focusing on 4 single herbs,
2 combinations of 2 herbs, and 11 multi-herbal prescriptions
involving 3 or more components. For a summary of the
investigated studies, see Table 2.
4. Single Herbs or Single Herbal Compounds
4.1. Evodiae fructus. In terms of TCM theory, Evodiae fructus
has been used for nausea and pain caused by cold exposition
[24–26]. Evodiamine, a major compound of Evodiae fructus,
was found to inhibit inducible nitric oxide synthase (iNOS)
and nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-𝜅B) activation, as well as the cyclo-oxygenase-2
(COX-2) expression, hypoxia-inducible factor 1-alpha (HIF-
1-𝛼) accumulation and prostaglandin E-2 (PGE-2) synthe-
sis, and interferon-gamma (INF-𝛾) mediated processes in
murine 264.7 macrophage-like cell lines [27].
Application of Evodiae fructus extract on acupoint
Yongquan (KID1) was reported to have positive effects on
mucositis symptoms in 92% of chemotherapy patients in an
uncontrolled case study (𝑛 = 50) measured by subjective
scales [28]. Ulcer grading has not been mentioned [28]. The
result requires further investigationwith higher-quality study
designs.
4.2. Rhodiola algida. Rhodiola subspecies are used as com-
mon tonics in various Asian regions. In Tibetan medicine,
it has an ancient tradition for its antifatigue effects, as well
as for cardiovascular diseases, pneumonia, and hemoptysis
[29]. Rhodiola algida is externally used for injuries, burns,
and scalds [29] and has shown immunomodulatory effects by
interleukin 2 (IL-2) regulation inTh-1 cells and interleukin 4,
6, and 10 (IL-4, IL-6, IL-10) regulation in Th-2 cells [30]. In
a randomised, controlled, two-armed clinical study on breast
cancer patients (𝑛 = 130; treatment: 𝑛 = 65; control: 𝑛 = 65)
[31], oral administration of Rhodiola algida resulted in faster
recovery of white blood cell count as well as fewer and smaller
ulcers compared to the non-treatment control group, judged
by clinical measurement. Furthermore, positive effects of
Rhodiola algida on lymphocyte proliferation was reported
while animal feeding with Rhodiola algida did not show toxic
effects [31].These findings are promising, but so far no further
trials confirming the results have been found.
4.3. Catechu from Acacia catechu. Catechu is an extract of
Acacia catechuwhich is clinically used for tissue regeneration,
wound healing, sores and abscesses as well as mouthwash for
oral ulcers [26, 32]. In combinationwith Scutellariae baicalen-
sis radix, anti-inflammatory effects are reported in animal and
human immortalized cell lines [33]. Local application ofCate-
chu powder had a superior effect on oral mucositis compared
to local norfloxacin application in a randomized, controlled,
two-armed clinical study on chemotherapy patients (𝑛 = 60;
treatment: 𝑛 = 30; control: 𝑛 = 30), judged by clinical
measurement [34]. Amelioration occurred in all patients
(100%) treated with Catechu and in 73.3% of the norfloxacin
group. Further trials confirming this result have not been
found.
4.4. Kangfuxin from Periplaneta americana. Kangfuxin is
an ethanolic extract of Periplaneta americana, used for its
anti-inflammatory and wound healing qualities in ulcerative
and inflammatory diseases, including recurrent aphthous
ulcers [35]. Regulating effects of the cytokine expression IL-
4, interleukin 5 (IL-5), IFN-𝛾, and TNF-𝛼 by decreased gene
expression have been reported [36]. In a randomized, con-
trolled, two-armed clinical study on chemotherapy patients
(𝑛 = 64; treatment: 𝑛 = 26; control: 𝑛 = 38), topical
Kangfuxin application showed an oral mucositis rate of 36%,
compared to saline gargling with amucositis rate of 84% [37].
This result as well requires verification by more trials with
high-quality study designs.
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5. Herbal Combinations
5.1. Lonicerae flos Plus Glycyrrhizae radix. Lonicerae flos
and Glycyrrhizae radix are two important ingredients of the
traditional herbal formula Yin Qiao San (Chinese) (Honey-
suckle and Forsythiae Powder (English), Pulvis Lonicerae et
Forsythiae (Latin)) from Wen Bing Tiao Bian (Systematic
Differentiation of Warm Diseases) [38]. It is used in inflam-
matory conditions including those of skin and mucosa [39,
40]. In TCM tradition, Lonicerae flos is used for abscesses,
swelling, ulcers and erysipelas [24–26]. It offers antioxidant
properties, suppressing interleukin 1-beta (IL-1𝛽), IL-6, and
COX-2 gene expression in human umbilical vein cells [41].
In traditional treatment, Glycyrrhizae radix is known to be
useful for abscesses, scores, and ulcer treatment [24–26].
Anti-inflammatory effects are transmitted by variant com-
pounds. Glycerol inhibits lipopolysaccharide (LPS)-induced
NF-𝜅B, IL-1, and IL-6 mRNA activation, while liquiritigenin
was found to inhibit the activation of NF-𝜅B inmacrophages,
decreasing iNOS and proinflammatory cytokines by inhibi-
tion of LPS-induced NF-𝜅B DNA binding activity [42, 43].
This herbal combination has been investigated by two
authors. In one randomized, controlled, two-armed clinical
trial, the combined topical and internal use was compared to
borax mouth washing in chemotherapy patients (𝑛 = 190;
treatment: 𝑛 = 97; control: 𝑛 = 93). Mucositis symptoms
were found in 19.4% of treatment group patients and in
85.2% of control group patients, measured by theWHO scale
for mucositis [44]. The study did not establish a control
for the internal use of herbal medicine, comparing a dual-
mode treatment to a single control. In another clinical trial
on chemotherapy patients (𝑛 = 86; treatment: 𝑛 = 43;
control: 𝑛 = 43), herbal gargling solution was compared
to hydrogen peroxide mouth washing [45]. Positive effects
on mucositis symptoms were found in 95.3% of the herbal
treatment group and 76.7% of the control group, measured
by a subjective scale. Further investigation by high-quality
studies is required.
5.2. Lonicerae flos Plus Glycyrrhizae radix Plus Astragali
membranacei radix. In this formula, Astragali membranacei
radix is used in addition to the herbs described above,
Lonicerae flos and Glycyrrhizae radix. In traditional use,
Astragali membranacei radix clears toxicity and is used for
abscesses and promoting skin regeneration [24–26]. It has
anti-inflammatory and immunoregulatory effects due to IL-2
and IFN-𝛾 release and IL-4 and iNOS suppression [46].
Topical use of this triple combination on oral mucositis
was effected in a randomized, controlled, two-armed clinical
trial (𝑛 = 97; treatment: 𝑛 = 50; control: 𝑛 = 47), with
positive results compared toDobell’s solution (sodium borate,
sodium bicarbonate, phenol and glycerol) [47]. The herbal
treatment group showed an overall lower grade of ulcers.
30% did not show any mucositis symptoms while only 2%
suffered from severe ulcers. In the Dobell’s solution control
group, 5% had remained without ulcers while 21.3% suffered
from severe ulcers. There was no statistical difference in the
duration of healing period. In addition to the investigated
drugs, all patients received a basic treatment by intravenous
injections of the Chinese herbal preparations Shengmai (Gin-
seng radix,Ophiopogonis radix, Schisandrae chinensis fructus),
Shenqi Fuzheng (Codonopsis radix, Astragali membranacei
radix), Ai Di (Acanthopanacis radix, Astragali membranacei
radix, Ginseng radix) and Cantharidin, as well as vitamin
supplements not further described, and tetracaine solution
for local application. In total, this is a strongly tonifying
herbal regime. Regarding this treatment by applying several
intravenously administered herbs, significant conclusions on
the investigated herbs of the gargle solution cannot be drawn
due to various potential interactions between the single
components.
5.3. Lonicerae flos Plus Ophiopogonis radix Plus Platycodo-
nis radix. Lonicerae flos and Ophiopogonis radix are part
of the classical herbal combination called Qing Ying Tang
(Chinese), Clear the Ying Level Decoction (English), Decoctum
Refrigerationis Qi Constructivi (Latin) from Wen Bing Tiao
Bian (Systematic Differentiation of Warm Diseases) [38],
which is composed by Rhinoceri cornu, Rehmanniae viridae
radix, Scrophulariae radix, Lophatheri folium, Lonicerae flos,
Forsythiae fructus, Coptidis rhizoma, Salviae miltiorrhizae
radix and Ophiopogonis radix. It is used for certain forms of
fever accompanied by a dry mouth [39, 40]. Ophiopogonis
radix and Playcodonis radix are combined in Bai He Gu Jin
Tang (Chinese), Lily Bulb Decoction To Preserve The Metal
(English), DecoctumFirmansMetallum cumLilio (Latin) from
Yi Fang Yi Jie (Analytic Collection of Medical Formulas)
[57], used for dry pharyngitis and bronchitis [39, 40]. Both
formulas have other principal herbs whose effects are assisted
by Lonicerae flos, Ophiopogonis radix and/or Platycodonis
radix [39, 40].
In TCM theory, Ophiopogonis radix is used for sore
throats and dry coughs [24–26]. There are scarce reports
about single molecular mechanisms of Ophiopogonis radix.
Opaw-2, a compound from Ophiopogonis radix, showed
dose-dependent stimulation of lymphocyte proliferation in
vitro [58]. Platycodonis radix had been traditionally used for
relieving soreness, expelling pus and for treating general skin
and mucosal diseases [24–26]. Platycodonis radix Saponins
derived from Platycodonis radix showed anti-inflammatory
effects via inhibition ofCOX-2, TNF-𝛼, andPGE2 expression,
as well as reduction of inflammatorymarkers like the number
of leukocytes and neutrophiles and edema [59].
For Lonicerae flos, see above.
This triple combinationwas investigated in a randomised,
controlled, two-armed clinical trial on chemotherapy patients
(𝑛 = 65; treatment: 𝑛 = 30; control: 𝑛 = 35). The treatment
group patients received oral herbal administration while the
control group patients used furacilin mouth washing and
received oral administration of vitamins B1 and C and daily
intravenous infusions of metronidazol. Basic treatment was
performed by saline gargling accompanied by diet instruc-
tions. The herbal treatment group showed improvement of
ulceration in 93%, compared to 73.8% in the control group,
classified by subjective scales of ulcer size [48]. In this trial,
diversified control interventions impede the comparability to
the treatment intervention.
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5.4. Lonicerae flos Plus Glycyrrhizae radix Plus Chrysanthemi
flos Plus Ganoderma lucidum Plus Menthae haplocalycis
herba. A Lonicerae flos, Glycyrrhizae radix and Menthae
haplocalycis herba combination is found in Yin Qiao San
[39, 40] as described above. AChrysanthemi flos,Glycyrrhizae
radix and Menthae haplocalycis herba combination is found
in Sang Ju Yin (Chinese), Clear Wind Heat Tea (English)i
Potio Mori et Chrysanthemi (Latin) from Wen Bing Tiao
Bian [38] which contains Mori folium, Chrysanthemi flos,
Armeniacae semen, Forsythiae fructus, Menthae haplocalycis
herba, Platycodi radix, Glycyrrhizae radix, and Phragmitis
rhizome and is used in beginning fever and coughing [39, 40].
Ganoderma lucidum has not been found in these classical
combinations.
In TCM theory, Chrysanthemi flos is used for septic
wounds and abscesses [24–26]. Chrysanthemi flos com-
pounds inhibit NO, PGE-2, TNF-𝛼, and IL-1𝛽 production,
as well as iNOS and COX-2 expression in LPS-induced
macrophages [60]. Ganoderma lucidum showed positive
effects on intestinal epithelium healing [61] and refractory
diabetic wounds [62] and was found to decrease NO, PGE-
2, and proinflammatory cytokine production, including IL-
1𝛽, TNF-𝛼 andNF-𝜅B inmicroglia [63].Menthae haplocalycis
herba in TCM theory is used for mouth sores, exanthema,
and itching [24–26]. It showed antimicrobial activity against
streptococcus mutans [64] and attenuated histamine release
and PGD-2 synthesis in mast cells [65].
For Lonicerae flos and Glycyrrhizae radix, see above.
The decoction of Lonicerae flos, Glycyrrhizae radix, Gan-
oderma lucidum, Chrysanthemi flos, and Menthae haplo-
calycis herba was prepared for local ice cube application
and compared to ambient tempered Dobell’s gargle solution
(sodium borate, sodium bicarbonate, phenol, and glycerol)
in a randomised, controlled, two-armed clinical trial on
gynaecological tumor patients receiving 5-FU chemotherapy
(𝑛 = 217; treatment: 𝑛 = 84; control: 𝑛 = 133) [49]. The
mucositis incidence resulted in 13.1% in the herbal treatment
group and in 39.1% in the control group.The study design did
not consider the fact that single ice application is known to
have a preventive effect on oral mucositis in patients treated
with 5-FU [1, 66], as there was no similar application design
for both groups.
5.5. Shengmai San (Chinese), Generate the Pulse Powder
(English). Shengmai San contains Ginseng radix, Ophiopogo-
nis radix, and Schisandrae chinensis fructus and originates
fromYuXueQi Yuan (Expounding on theOrigins ofMedicine)
[67]. It is used in multiple clinical patterns including car-
diovascular and neurologic disorders, diabetes, and cancer
for its tonifying and yin nourishing properties [39, 40].
Regarding the single compounds, there are multiple reports
about anti-inflammatory effects of ginsenosides by inhibi-
tion of proinflammatory cytokines and other mediators of
inflammation including iNOS, NO, IF-𝛾, COX-2, NF-𝜅B, and
TNF-𝛼 [68]. Ginsenoside Rd showed wound healing effects
on skin level, increasing the proliferation and migration
of keratocyte progenitor cells and dermal fibroblasts by
cyclic adenosine monophosphate (cAMP) induction via 9-𝛽-
d-arabinofuranoside attenuation [69]. Schisandrae chinensis
fructus in terms of TCM theory is astringent and preserving
fluids [24–26]. Schisandrin B was found to inhibit ataxia
telangiectasia and Rad3-related (ATR) protein kinase activity
following DNA damage by inhibition of phosphorylation
processes [70]. A hydrophobic fraction of dried Schisandrae
chinensis fructuswas found to suppress IL-𝛽-inducedNO and
iNOS expression, as well as the transcription of IL-1𝛽 and
inflammatory cytokines [71].
For Ophiopogonis radix, see above.
In a randomised, controlled, two-armed clinical trial
(𝑛 = 71; treatment: 𝑛 = 36; control: 𝑛 = 35) on acute
chemotherapy toxicity regarding primarily white blood cell
and platelet counts as well as nausea, vomiting, and oral
mucositis, intravenous Shengmai injection was compared to
dexamethasone, metoclopramide, and ondansetron injection
(which targeted nausea and vomiting rather than mucositis
due to the ampler study design). Oral mucositis occurred in
5.5% of the treatment group and in 28.5% of the control group
[50].The control intervention of this trial was not specific for
oral mucositis.
5.6. Bubali Cornu and Callicarpae macrophyllae folium.
Bubali cornu is frequently found as modern substitute for
Rhinoceri cornu (forbidden due to the Convention on Inter-
national Trade in Endangered Species of Wild Fauna and
Flora, also known asWashington Convention) in the classical
formula Qing Ying Tang (see above). There are no classical
formulas combining these two drugs, but this is a modern
empirical combination called Shui Zhong Cao Tang Ji (Chi-
nese), Water Grass Decoction (English). In terms of TCM the-
ory, Bubali cornu has effects similar to Rhinoceri cornu, used
for febrile diseases, exanthema, and convulsions [24–26]. It
has shown antipyretic and antioxidant effects on proteins
and inhibition of TNF-𝛼-induced PGE2 production, as well
as protection against hydrogen peroxide (H
2
O
2
)-induced
injuries in rat cerebral microvascular endothelial cells [72].
Callicarpae macrophyllae folium is reported to be used in
TCM tradition for bleedings, hematoptysis, and hematemesis
[26]. Anti-inflammatory, antimicrobial, and analgesic effects
of Callicarpae macrophyllae folium are reported but not yet
fully investigated [73].
This formula was topically and internally administered
in a randomised, controlled, three-armed clinical trial (𝑛 =
88; treatment: 𝑛 = 30; first control: 𝑛 = 30; second
control: 𝑛 = 28) to chemotherapy patients, compared to
topical application of gentamycin, tetrahydropholate, and
saline gargling (first control) and to oral oryzanol admin-
istration (second control) [51]. There was a mean better
outcome of curative voted cases from herbal treatment to the
gentamycin/tetrahydropholate/saline control group (53.3% to
50.0%). General improvement of oral mucositis symptoms
was seen in 93.3% of both groups. Oral mucositis symptoms
remained in 92.2% of the oryzanol group, showing an
advantage of the two former regimens compared to oxyzanol
administration alone. The comparison of the combined
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topical and internal use to a single control intervention does
not allow significant conclusions.
5.7. Huang Wu Shu Kou Ye (Chinese), Yellow Five Decoction
(English) (Phellodendri Chinensis Cortex, Forsythiae fructus,
Verbenae officinalis herba, Borneolum, Galla chinensis, and
Catechu). The name of this empirical prescription may be
borrowed from Dang Gui Liu Huang Tang, Angelica Six
Yellows Decoction (English), Decoctum Angelicae Sinensis et
sex Luteorum (Latin) from Lan Shi Mi Cang (Sectrets from
the Orchid Chamber) [74], as Phellodendri chinensis cortex
is one of the contained 6 yellow coloured drugs (Rehman-
niae viridae radix, Rehmanniae preparata radix, Coptidis
rhizoma, Scutellariae baicalensis radix, Phellodendri chinensis
cortex, and Astragali membranacei radix). The combination
of Phellodendri chinensis cortex, Forsythiae fructus, Verbenae
officinalis herba, Borneolum, Galla chinensis, and Catechu has
not been found in classical prescriptions.
Phellodendri chinensis cortex is traditionally considered
as anti-toxic and is used for abscesses and sores [24–26]. It
was found to inhibit TNF-𝛼, IL-1𝛽, and iNOS production,
as well as phosphorylation of extracellular-signal regulated
kinases (ERK) and NF-𝜅B activation in microglia cells [75].
Forsythiae fructus has a traditional use as anti-toxin as well
as for erysipelas and abscesses [25–27]. A Forsythiae fructus
compound, arctiin was found to decrease proinflammatory
cytokine production including IL-1𝛽, IL-6, TNF-𝛼, and PGE-
2, as well as NF-𝜅B and co-stimulating molecules such
as peripheral membrane protein B7-1 and B7-2 in mouse
leukaemic monocyte macrophage cell line (RAW 264.7)
cells [76]. Verbenae officinalis herba in TCM terms removes
toxicity and is used for sores and boils as well as pharyngitis
[26, 77]. Verbenae officinalis herba extractions were found to
possess antioxidant, anti-inflammatory, and wound-healing
properties [78]. Borneolum is a crystal steam distilled prod-
uct of Cinnamomum camphora [26]. It is used externally for
mouth sores, ulcerations, and wounds [24–26] and showed
anti-inflammatory and antioxidant cell protective effects by
decreasing iNOS expression, NO, and inflammatory factor
release, as well as NF-𝜅B translocation and caspase-related
apoptosis in an ischemic/reperfusion neuron model [79].
Galla chinensis in TCM theory astringes, promotes wound
healing and is used for ulcers and edema [24–26].
For Catechu, see above.
A gargle solution composed by these 5 herbs as well as
saline gargle solution was administered in a randomised,
controlled, two-armed clinical trial (𝑛 = 101; treatment:
𝑛 = 53; control: 𝑛 = 48) to chemotherapy patients, com-
pared to Borax solution gargling alone. All patients received
basic treatment with antibiotics and vitamin supplements
not further described. Improvement on mucositis symptoms
was seen in 96.2% of the treatment group and 76.1% of
the control group, judged by subjective clinical scales [52].
Significant conclusions on this result cannot be drawn as
antibiotic regimens may have interfered with possible anti-
inflammatory effects of the herbal solution used at the same
time.
5.8. Yu Nu Jian (Chinese), Jade Woman Decoction (English).
This classical TCM formula containing Gypsum fibrosum,
Rehmanniae viridae radix, Anemarrhenae rhizoma, Ophio-
pogonis radix, and Achyranthis bidentatae radix, is described
in Collected Treatises of Zhang Jing Yue [80]. It is used for
inflammatory diseases including oral ulcerations [39, 40].
Gypsum fibrosum is traditionally used for burns and ulcers
[24, 25] as well as for fever [24–26], and it showed antipyretic
activity demonstrated against LPS-induced pyrexia in rats,
while calcined Gypsum and CaSO
4
did not have this effect
[81].Rehmanniae viridae radix had been traditionally used for
exanthema, abscesses, and sore throats [24–26]. Compounds
of Rehmanniae viridae radix were found to inhibit NO
production and iNOS, PGE-2, IL-6, and COX-2 expression
in RAW264.7macrophages [82].Anemarrhenae rhizoma had
been traditionally used for dry coughs and infectious diseases
[24–26]. Nyasol, a compound ofAnemarrhenae rhizoma, was
found to reduceNO and PGE-2 production as well asmRNA-
levels of TNF-𝛼 and IL-1𝛽 in LPS-stimulated microglia cells.
P38 mitogen-activated protein kinase (p38MAPK) was inac-
tivated and LPS-induced I-𝜅B𝛼 degradation was suppressed
[83]. Achyranthis bidentatae radix calms bleeding from the
mucosa in TCM theory and is used for mouth soreness,
epistaxis, and hematemesis [24–26]. Achyranthis bidentatae
polysaccharides derived from Achyranthis were found to
positively modulate murine dendritic cell maturation by cell
surface molecules CD86 and CD40 and major histocompat-
ibility complex II (MHC II) enhancement and increase IL-
12 production, indicating a possible immune boosting effect
[84].
As Yu Nu Jian was investigated with Qing Wei San (see
below) in one study, oral mucositis related results are stated
below.
5.9. Qing Wei San (Chinese), Clear the Stomach Powder
(English). This classical TCM formula contains Coptidis
rhizoma, Cimicifugae rhizoma, Rehmanniae viridae radix,
Moutan cortex, Angelicae sinensis radix, and Achyranthis
bidentatae radix. It is described in Lan Shi Mi Cang (Secrets
from the Orchid Chamber) [74] and used for gingivitis and
inflammations of tongue and lips.
In terms of TCM theory, Coptidis rhizoma is regularly
used in inflammatory and septic processes [24–26]. It was
found to inhibit IL-1𝛼, IL-6, and granulocyte macrophage
colony-stimulating factor (GM-CSF) secretion, iNOS expres-
sion, and NO production in RAW 264.7 macrophages [85].
Cimicifugae rhizoma in TCM terms removes toxicity and is
used in exanthema, mucosal inflammation, and ulceration
[24–26]. It was found to reduce LPS-induced release of IL-
6, TNF-𝛼, IFN-𝛾, and stimulation of IL-8 in LPS-induces
human blood cells [86].Moutan cortex in TCM terms is used
in cases of inflammation and mucosal bleeding [24–26]. It
was found to inhibit the activation of several inflammation-
related genes in gingival fibroblasts [87]. Angelica sinensis
radix is used for sores, ulcers, and abscesses in TCM theory.
Ligustilide, an Angelica sinensis radix compound, was found
to suppress NO production, PGE-2, and TNF-𝛼 in LPS-
stimulated RAW 264.7 macrophages, to decrease activator
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protein-1 (AP-1), iNOS and NF-𝜅B activation, phosphory-
lation of I𝜅B kinase (IKK), MPAKs, ERK1/2, and c-Jun-N-
terminale kinase (JNK) and to downwardly regulate intracel-
lular reactive oxygen species (iROS) [88].
For Rehmanniae viridae radix andAchyranthis bidentatae
radix, see above.
Both YuNu Jian (see above) andQingWei Sanwere inves-
tigated in an uncontrolled case study on leukaemia patients
(𝑛 = 31), clinically allocated into two groups according to
the criteria of exuberance or deficiency by terms of TCM
theory. Yu Nu Jianwas administered to the exuberance group
whileQingWei Sanwas administered to the deficiency group.
Additional topical medication was effected in all patients
without further description. Ulcer grading was clinically
judged. Reported without group differentiation, 7 patients
obtained very good results and 19 patients offered good
results onmucositis symptoms, indicating an improvement of
83.9% in summary [53]. In the context of a scientific study, the
simultaneous use of different formulas precluded significant
results. The findings require further investigation by higher-
quality trials.
5.10. Chrysanthemi flos Plus Gardeniae fructus Plus Hyperici
perforati herba Plus Scrophulariae radix Plus Sophorae tonk-
inensis radix Combination. Classical combinations of these
herbs have not been found. Obviously, the formula was
empirically composed with the purpose of obtaining anti-
inflammatory and wound-healing effects. In terms of TCM
theory, Gardeniae fructus had traditionally been externally
used for wounds and contusions [24–26]. Geniposide from
Gardeniae fructuswere found to inhibit TNF-𝛼, IL-6, and IL-
1𝛽, to block the phosphorylation of I𝜅B𝛼 and transcription
factor p65 and p38, as well as extracellular-signal-regulated
kinases (ERK) and c-Jun N-terminal kinases (JNK), and to
decrease the toll-like receptor-4 (TLR4) expression in LPS-
simulatedmacrophages.Theywere also found to decrease the
LPS-induced IL-8 production in human embryonic kidney
cells (HEK293-mTLR4/MD-2 cells) [89]. Hyperici perforati
herba is astringent and expels toxins in TCM theory [26].
Hyperici perforati herba compounds were found to inhibit
LPS-induced PGE-2, COX-2, and NO through the suppres-
sion of cytokine signaling 3 (SOCS3) activation in 264.7
macrophages [90]. Scrophulariae radix in TCM theory is
classified as removing toxicity and moistening tissues; it is
used for sores and exanthema [24–26]. Sophorae tonkinensis
radix had been traditionally used for tonsillitis, pharyngitis,
and mouth sores [26, 91]. It is toxic in higher doses. In vitro,
it showed antiviral activity on Coxsackie-, Echo-, and Polio-
virus [92].
For Chrysanthemi flos, see above.
As this prescription was investigated in one study with
Qing Dai San (see below), mucositis related results are stated
below.
5.11. Qing Dai San. Borax and Borneolum combination is
found in Bing Peng San (Chinese), Borneol and Borax Powder
(English), Pulvis Borneoli et Boracis (Latin), as a locally used
prescription for oral inflammation and aphthous ulceration
from Yi Zong Jin Jian (Golden Mirror of the Medical Tra-
dition) [93]. An alternative to this prescription, Qing Dai
San contains Borax, Borneolum, and Indigo naturalis [39, 40].
Borax is an extract of natural borax mineral. In terms of
TCM theory, it removes toxicity from skin and mucosa upon
external application [24, 25]. Borax compounds were found
to reduce genotoxic effects of heavymetal exposure of human
blood cell cultures by arsenic, bismuth, cadmium, mercury,
and lead, normalising decreased antioxidant enzyme activ-
ities as well as sister chromatid exchange and micronu-
clei and plasma malondialdehyde (MDA) levels [94]. High
Borax doses showed toxic cellular effects, decreasing human
lymphocyte proliferation and increasing sister chromatid
exchange in chromosomes [95].
Indigo naturalis is the fermented and chalked extract
of Strobilenthes flaccidifolius, Indigo tinctoria, Isatis oblon-
gata or Polygonaum tinctorium. It is used for exanthema
and ulcers in TCM [24–26] and was found to to inhibit
superoxide anione generation as well as MPAK phosphory-
lation and calcium mobilisation in formyl-methionyl-leucyl-
phenylalanine (FMLP)-activated human neutrophils [96].
For Borneolum, see above.
The compositions 5.10 and 5.11 were investigated together
in a randomised, controlled, four-armed clinical trial on
both chemotherapy- and radiation-induced oral mucositis.
This article refers only to the two-armed part concerning
chemotherapy patients (𝑛 = 60; treatment: 𝑛 = 30;
control: 𝑛 = 30). The decoction of Chrysanthemi flos,
Gardeniae fructus, Hyperici perforate herba, Scrophulariae
radix, and Sophorae tonkinensis radixwas orally administered
to the treatment group who also used a gargle solution
composed of Borax, Borneolum, and Indigo naturalis. The
control group patients received vitamin B12 administration
and used a gentamycin/sodium//bicarbonate gargle solution.
Ulcer grading was defined by size and quantity of ulcers.
Improvement on oral mucositis symptoms were found in
96.7% of the herbal treatment group, compared to 86.7% in
the control group. An overall shorter healing period for the
herbal treatment group was reported [54]. In this trial, the
investigation of two formulas at the same time compared to
disparate controls impeded clear results.
5.12. Codonopsitis radix Plus Atractylodis macrocephalae Rhi-
zome Plus Glycyrrhizae radix Plus Angelicae sinensis radix
Plus Rehmanniae viridae radix Plus Astragali membrana-
cei radix Plus Dioscoreae oppositae rhizoma Plus Alismatis
rhizoma Plus Agastachis herba Plus Lophatheri herba. This
formula may be regarded as a modified incomplete Ba Zhen
Tang (Chinese), Eight Treasure Tea (English), Decoctum
octo Gemmarum (Latin), from Zhen Ti Lei Yao (Cata-
logued Essentials for Correcting the Body) [97], which is a
strong formula for devitalised patients, composed by Gin-
seng radix (or alternatively Codonopsitis radix), Atractylodis
macrocephalae rhizoma,Glycyrrhizae radix,Angelicae sinensis
radix, Rehmanniae radix, Poria alba, Paeoniae alba radix,
and Ligustici chuangxiong rhizoma [39, 40]. In prescription
5.12, the last three herbs of Ba Zhen Tang were replaced
by Astragali membranacei radix, Dioscoreae oppositae radix,
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Alismatis rhizoma, Agastachis herba, and Lophatheri herba,
directing the prescription to immune consolidating effects
[24–26].
Agastachis herba, Atractylodis macrocephalae radix, and
Glycyrrhizae radix are found inHuoXiangZhengQi San (Chi-
nese), Agastache Powder to Rectify the Qi (English), Pulvis
Agastachis pro Qi Orthopathico (Latin) from Tai Ping Hui
Min He Ji Ju Fang (Imperial Grace Formulary of the Tai Ping
Era) [98] withMagnoliae cortex, Citri reticulatae pericarpium,
Perillae folium, Angelica dahuricae radix, Pinelliae rhizoma,
Arecae pericarpium, Poria alba, and Platycodonis radix. It is
used for endemic infections and gastritis [39, 40]. Alisma-
tis rhizoma, Codonopsitis radix, Atractylodis macrocephalae
rhizoma, Angelicae sinensis radix, and Glycyrrhizae radix are
also found in Dang Gui Nian Tong Tang (Chinese), Decoction
to Lift the Pain (English) from Nei Wai Shang Bian Huo Lun
(Clearing Doubts about Injury from Internal and External
Causes) [99] with Atractylodis radix, Ledebouriellae radix,
Puerariae radix, Scutellariae radix, Anemarrhenae rhizoma,
Artemisiae herba, Polyporus, Sophorae radix, Notopterygii
radix, and Cimicifugae radix. It is used for inflammatory
diseases such as arthritis, impetigo, and eczema [100].
Codonopsitis radix extract was found to inhibit NO, TNF-
𝛼, IL-3 IL-6, and the ERK signalling pathway as well as
LPS-induced phagocytic uptake and CD29-mediated cell-
cell-adhesion in RAW 264.7 macrophages [101]. Dioscoreae
oppositae rhizoma was found to decrease the NO and
proinflammatory cytokine production including IL-1𝛽, Il-
6, TNF-𝛼, and PGE-2, as well as iNOS, and the COX-2,
and NF-𝜅B activation in RAW 264.7 macrophages [102].
Alismatis rhizoma is diuretic in TCM theory [24–26]. It
is not typically used for oral diseases but was found to
suppress NF-𝜅B, COX-2, IL-1𝛽 and iNOS, as well as induced
nuclear factor-like 2 (Nrf2)-regulated gene expression in
RAW 264.7 cells [103]. Agastachis herba in TCM theory
has antiedematous effects and is used for nausea and fever
[24, 25]. Agastachis herba extract showed antioxidant effects
increasing heme oxygenase-1 (HO-1) enzyme activity by way
of the protein kinase G (PKG) signalling pathway in RAW
264.7 macrophages [104]. Lophatheri herba has been tradi-
tionally used for mouth and tongue sores [26]. Glycosides
derived from Lophatheri herbawere found to possess an anti-
respiratory syncytial virus (RSV) effect in vitro [105].
For Atractylodis macrocephalae rhizoma, Glycyrrhizae
radix, Astragali membranacei radix, Angelicae sinensis radix,
and Rehmanniae viridae radix, see above.
The decoction of Codonopsitis radix, Atractylodis macro-
cephalae rhizoma,Glycyrrhizae radix, Angelicae sinensis radix,
Rehmanniae viridae radix, Astragali membranacei radix,
Dioscoreae oppositae rhizoma, Alismatis rhizoma, Agastachis
herba, and Lophatheri herba was administered in a ran-
domised, controlled, two-armed clinical trial (𝑛 = 66;
treatment: 𝑛 = 33; control: 𝑛 = 33) to chemotherapy
patients during 4 chemotherapy cycles. The treatment group
received not only the herbal decoction but also a multi
vitamin, mineral, and micronutrient supplement (Centrum
Wyeth). The control group patients received only vitamin B2
administration. Oral ulcer incidence grew from the first to
the fourth chemotherapy cycle up to 21.2% in the treatment
group and 66.7% in the control group, judged by WHO scale
for Oral Mucositis. The increase was not only higher but also
faster in the control group [55].
In this trial, the diversified vitamin supplement applica-
tion confused the effect of the herbal medicinal treatment.
Vitamin B2 is not a valuable control to any multivitamin
supplement and/or Chinese medicinal herbs. Basic condi-
tions should be equal in both groups in order to achieve a
measurable effect. The effect of vitamin supplements should
be investigated independently from herbal medicine.
5.13. Modified Xie Huang San (Chinese), Drain the Yellow
Powder (English). The classical prescription Xie Huang San
contains Gypsum fibrosum, Saposhnikoviae radix, Garde-
niae fructus, Agastachis herba, and Glycyrrhizae radix. It is
described in Xiao Er Yao Zheng Zhi Jue (Craft of Medicines
and Patterns for Children) [106] and used for inflammatory
diseases of stomach and mouth [39, 40].
Saposhnikoviae radix is used for affections of skin and
mucosa [24–26]. It was found to inhibit NO production
through iNOS and its mRNA expression in LPS-induced
RAW 264.7 cells [107].
For the further herbs of this formula, see above.
Modifying standard prescriptions by herb addition
related to syndrome patterns or individual symptoms is
common in TCM tradition [39, 40]. In a clinical trial on 90
chemotherapy patients [56],XieHuang Sanwas administered
amended by addition of Ginseng radix, Astragali membrana-
cei radix, Atractylodis macrocephalae rhizoma, Coptidis rhi-
zoma, Taraxaci herba, Dendrobii caulis, Hedyotidis herba, and
Lophatheri herba which offer additional anti-inflammatory
qualities [24–26].
In terms of TCM theory, Taraxaci herba is used for
swelling, abscesses, and sore throat [24–26]. Taraxacosterol
a flavonoid, isolated from Taraxaci herba, was found to
inhibit NO, PGE-2, TNF-𝛼, IL-1𝛽, and IL-6 production as
well as LPS-induced NF-𝜅B translocation in RAW 264.7
macrophages [108]. Dendrobii caulis had been used for dry
mouth in TCM theory [26]. Anti-inflammatory and saliva
secretion increasing effects ofDendrobii cauliswere indicated
in a Sjo¨gren’s mouse model [109]. Hedyotis herba in TCM
theory has been used for abscesses and ulcers [24, 25].
For Ginseng radix, Atractylodis macrocephalae rhizoma,
Coptidis rhizoma, and Lophatheri herba, see above.
Astragali membranacei radix, Atractylodis macrocephalae
rhizome, andGinseng radix are found in Bu Zhong Yi Qi Tang
(Chinese), Tonify the Middle and Augment the Qi Decoction
(English), Decoctum Suppleens Centrum et Augmentans Qi
(Latin) from Nei Wai Shang Bian Huo Lun (Clearing Doubts
about Injury from Internal and External Causes) [99] with
Glycyrrhizae radix tosta, Angelicae sinensis radix, Auran-
tii pericarpium, Cimicifugae rhizoma, and Bupleuri radix.
Furthermore, Yu Ping Feng San (Chinese), Jade Windscreen
Powder (English), Pulvis Paraventi Jaspidis (Latin) from Shi
Yi De Xiao Fang (Effective Formulas from Generations of
Physicians) [110] composed of Astragali membranacei radix,
Atractylodis macrocephalae radix, and Saposhnikoviae radix,
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traditionally considered as consolidating the body’s immune
defence, is present in this multiple decoction.
This complex formula was investigated in the above-
mentioned randomised, controlled, two-armed clinical trial
on chemotherapy patients (𝑛 = 90; treatment: 𝑛 = 50;
control: 𝑛 = 40) by oral administration to the treatment
group [56]. In addition, several of their individual symptoms
were considered in each case by adding herbal modules.
In case of diarrhoea, neutropenia, thrombopenia, petechiae,
lymphadenopathy, fever, insomnia, night sweat, or increased
ministerial fire (which is a specific term of TCM theory), two
different herbs were added to the recipe.
This total of herbal medicine was compared to oral
administration of vitamin B2 and vitamin C in the control
group. All patients received dental care instructions and diet
advices. Ulcer degree was classified by a subjective clinical
scale.
Though positive effects on mucositis symptoms were
seen in 98% of the treatment group compared to 72% of
the vitamin control group, the formula complexity does
not allow congruent conclusions due to several variances
in the treatment group. The multiple interactions between
single herbal components do not allow a clear view on the
(formula’s) effects. Furthermore, vitamin application may be
useful for oral mucositis patients but does not represent a
valid control to any complex herbal prescription of this size.
6. Discussion
Chemotherapy-induced oral mucositis continues to be a
challenge for anticancer treatment [8, 9, 12–15], representing
one of themost commonproblems for chemotherapy patients
[1]. Despite of the dedicated research on this field [1–7] and
some resulting guidelines for prevention and treatment of
oral mucositis [9, 10, 16, 17], therapeutic results are not yet
satisfactory. Chemotherapy side effects in general represent
an additional physical and psychological burden to patients
diagnosed with cancer, reducing their quality of life and
leading to the risk of anticancer treatment delay with fatal
consequences [7, 8]. On the other hand, posttraumatic stress
reactions as seen in cancer patients lead to a decreased
defence against oral mucositis, determined by the alteration
of several biomarkers [6, 7].
Medicinal herbs are commonly used for complementary
treatment when there is no sufficient western treatment
concept. A Chinese review identified diverse approaches
regarding oralmucositis by applying herbalmedicine, includ-
ing various gargling preparations, sprays, formulas for oral
administration, acupoint application or intravenous injec-
tion, resulting in a generally positive effect [111], but the
evidence of herbal use on oral mucositis still remains unclear.
Generally, systematic review studies on Chinese herbal
medicine come to the conclusion that better qualified studies
are necessary [112–114]. At the clinical level, study designs
used to be mostly suboptimal but even on pharmacological
level, the study quality is criticized as being sufficient. This
is not surprising, because classical pharmacological research
is generally focusing on single active compounds and this
method of approach is not easily transferred to the multi-
dimensional complexity of Asian herbal prescriptions. But
in some aspects this view is short sighted, as a single-target
approach can have limited effectiveness, and there is some
evidence that amulti-target approachmight bemore effective
[115, 116] and mixtures may have potentiating actions of their
multiple bioactive components [117].
In this review, on the one hand we tried to summarize
the state of knowledge of Chinese herbal treatment for
chemotherapy-induced oralmucositis based on clinical trials.
On the other hand, we tried to examine the TCM tradition
based rationality of the particular herbs used for mucositis.
While aggressive treatments like chemotherapy have not
been used in the history of TCM, application of traditional
Chinese herbal treatment to these side effects of modern
therapy requires an intentional transfer of historical concepts
to modern treatment procedures. In daily practice, Chinese
herbal medicine has an individualized approach that cannot
be easily transferred into standardized controlled trials due
to the uniform treatment concepts usually required by con-
trolled trials.
For a full understanding of themechanisms of herbal pre-
scriptions, the effects of every single herb must be known on
a molecular basis. Based on these data, herbal combinations
should be investigated for detecting synergisms that may
result in molecular effects which are not found in the single
herb components [118, 119]. Further elaborated research is
necessary for clearing multiple questions about single as well
as combined herbal use, resulting in the aim of rational
prescription rather than application based only on empirical
knowledge.
Even though all reviewed clinical trials reported positive
effects of Chinese herbal treatment, they did not show ade-
quate study designs proportionately with regard to the inves-
tigated questions. Some studies used complex multi-herbal
formulas that lead to difficulties in understanding the detailed
effects. Formula complexity should be well elaborated in
order to achieve significant results. Monoherbal applications
offer clear results on the basis ofwell elaborated study designs.
Herbal combinations may be even more effective in clinical
results [115–117], while under clinical study conditions the
evidence of exaggeratedmulti-herbal application is narrowed
by numerous interferences between the single compounds,
especially in combined prescriptions of variant formulas (see
5.2, 5.10, 5.11, 5.12, and 5.13).
The use of individualized herbal combinations has a long
tradition in TCM on an empirical basis. One of the evaluated
trials tries to take this classical approach into account by
additional prescriptions depending on the accompanying
symptomatology, resulting in extremely complex treatment
procedures (see 5.13). In consequence, the general overview
gets lost. In other trials treatment procedures of topical
application and internal or even intravenous administration
were combined (see 5.1a, 5.3, 5.6, and 5.10 and 5.11), making
it impossible to draw applicable conclusions about one of the
interventions. One trial used a formula mixed with vitamins
(see 5.12), while others used vitamin B2, B12, and/or vitamin
C application for controls without discussing the rationale
(see 5.3, 5.6, 5.11, 5.12, and 5.13). In the same manner, it is
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difficult to judge the efficacy on herbal ice application versus
ambient tempered gargle solution (see 5.4). Antibiotics were
used for control groups in some studies (see 4.3, 5.6, and
5.11) while basic use of antibiotics challenged the result of one
study (see 5.7).
Only in one study a non-treatment group had been
established (see 4.2) and in only 6 studies the same type
of application was used for treatment as well as for control
groups (see 4.3, 4.4, 5.1b, 5.2, 5.5, and 5.7). Two authors
reported uncontrolled case studies (see 4.1, 5.8, and 5.9).
In summary it is almost impossible to evaluate which
parts of the treatment concepts are responsible for the
measured effects in the reviewed trials.
Another problem for judging study results is the fact
that oral mucositis is a severe but short term side effect of
chemotherapy, typically self-limiting in about 2 to 4 weeks
if not complicated by infections [1]. Study designs have to
consider that evenwithout any specific treatments, symptoms
possibly improve in this time.
In general, the investigated trials showed low-quality
designs. Control groupswere established inmost investigated
trials but control interventions did not represent any stan-
dards. It has to be admitted that the mucositis guidelines so
far existing are limited, so it is not easy to find valid control
interventions for some treatment concepts. But in general,
clinical studies should offer a standard basic treatment for all
patients or placebo non-treatment groups in order to gather
valid data on the investigated intervention. In the case of
mucositis, establishing non-treatment groups could cause an
ethical dilemma for having possible severe consequences [9,
12, 13] but it is possible to establish basic treatment conditions
for all patients taking part of the study which do not interfere
with the investigated intervention. This approach includes
placebo administration for control groups in order to achieve
valid data. In the case of Chinese medicinal herbs, the use
of capsules containing herbal extractions or placebo is a
good option. In the case of gargling solutions, fabricating
a valid placebo may be more complicated but should not
be impossible. Patients and medical practitioners should be
blinded regarding the applied intervention in order to min-
imize placebo effects. The blinding technique has not been
reported in any of the investigated studies. Randomisation
has been reported in all controlled studies though the process
has not been described except very briefly in two publications
(5.1b and 5.12). For proving a strict randomisation protocol
so as not to create bias, it is necessary to provide a detailed
description.
Summarizing the collected data so far, results of Chi-
nese medicinal herbal administration for chemotherapy-
induced oral mucositis are potentially promising, but poor
study designs do not allow valid conclusions. Conducting
a meta-analysis is not possible with the present database.
Further investigations are necessary on molecular mecha-
nisms of multi-herbal formulas and the corresponding single
herbs as well as in well designed clinical trials. Providing
adequate study designs are developed, traditional Chinese
herbal medicine has the potential of complementing western
regimens such as chemotherapy in order to achieve lower
levels of side effects, thus enabling patients to better resist
chemotherapy impacts.
7. Conclusion
All evaluated trials in this review reported positive effects
about Chinese herbal treatment for chemotherapy-induced
oral mucositis, but the value of these treatments remains
unclear. Study designs are generally poor, some herbal pre-
scriptions are far too complex and adequate controls are
missing. Mechanisms of action are rarely described.
While basic research provides data about anti-
inflammatory and protective effects of some herbs or
herbal compounds, further research is still promising, but
study designs need considerable improvement. So future
research should start withmechanism based studies first.The
following clinical studies should reduce the complexity of the
treatment procedures in order to produce clear results, before
Chinese herbal medicine can become an evidenced based
part of the treatment of chemotherapy induced mucositis.
Conflict of Interests
The authors declare that they have no conflict of interests.
References
[1] NationalCancer Institute, http://www.cancer.gov/cancertopics/
pdq.
[2] M. Rostock and R. Saller, “Schleimhautscha¨den unter
antitumoraler Behandlung: Pra¨ventive und therapeutische
Mo¨glichkeiten mit pflanzlichen Zubereitungen,” Schweizerische
Zeitschrift fu¨r Ganzheitsmedizin, vol. 19, no. 4, pp. 212–217, 2007.
[3] J. B. Epstein, A. H. F. Tsang, D. Warkentin, and J. A. Ship,
“The role of salivary function in modulating chemotherapy-
induced oropharyngeal mucositis: a review of the literature,”
Oral Surgery, OralMedicine, Oral Pathology, Oral Radiology, and
Endodontics, vol. 94, no. 1, pp. 39–44, 2002.
[4] C. Scully, J. Epstein, and S. Sonis, “Oral mucositis: a chal-
lenging complication of radiotherapy, chemotherapy, and
radiochemotherapy. Part 1, pathogenesis and prophylaxis of
mucositis,” Head and Neck, vol. 25, no. 12, pp. 1057–1070, 2003.
[5] D. E. Peterson and R. V. Lalla, “Oral mucositis: the new
paradigms,”Current Opinion inOncology, vol. 22, no. 4, pp. 318–
322, 2010.
[6] C. Xu, J. Zhao,W. T. Loo et al., “Correlation of epigenetic change
and identification of risk factors for oral submucous fibrosis,”
International Journal of Biological Markers, vol. 27, no. 4, pp.
e314–e321, 2010.
[7] L. J. Bai, Q. Liu, M.Wang et al., “Evaluation of the psychological
and biological changes of patients diagnosed with benign and
malignant breasttumors,” International Journal of Biological
Markers, vol. 27, no. 4, pp. e322–e330, 2012.
[8] D. McGowan, “Chemotherapy-induced oral dysfunction: a
literature review,” British Journal of Nursing, vol. 17, no. 22, pp.
1422–1426, 2008.
[9] C.Wojtaszek, “Management of chemotherapy-induced stomati-
tis,” Clinical Journal of Oncology Nursing, vol. 4, no. 6, pp. 263–
270, 2000.
Evidence-Based Complementary and Alternative Medicine 13
[10] D. M. Keefe, M. M. Schubert, L. S. Elting et al., “Updated
clinical practice guidelines for the prevention and treatment of
mucositis,” Cancer, vol. 109, no. 5, pp. 820–831, 2007.
[11] Mucositis Study Section of the Multinational Association
of Supportive Care in Cancer and The International Soci-
ety for Oral Oncology, “Mucositis, perspectives and clinical
practice guidelines, perspectives on cancer therapx-induced
mucosal injury,” http://www3.interscience.wiley.com/cgi-bin/
fulltext/108069519.
[12] F. K. L. Spijkervet and S. T. Sonis, “New frontiers in themanage-
ment of chemotherapy-induced mucositis,” Current Opinion in
Oncology, vol. 10, supplement 1, pp. S23–S27, 1998.
[13] S. A. Khan and J. R. Wingard, “Infection and mucosal injury
in cancer treatment,” Journal of the National Cancer Institute.
Monographs, no. 29, pp. 31–36, 2001.
[14] WHOHandbook, 1979.
[15] S. T. Sonis, L. S. Elting, D. Keefe et al., “Perspectives on cancer
therapy-induced mucosal injury,” Cancer, vol. 100, supplement,
no. 9, pp. 1995–2025, 2004.
[16] R. V. Lalla, S. T. Sonis, and D. E. Peterson, “Management of
oral mucositis in patients with cancer,” Dental Clinics of North
America, vol. 52, no. 1, pp. 61–77, 2008.
[17] 2013, http://www.mascc.org/mucositis-guidelines.
[18] H.V.Worthington, J. E. Clarkson,G. Bryan et al., “Interventions
for preventing oral mucositis for patients with cancer receiving
treatment,” Cochrane Database of Systematic Reviews, vol. 12, p.
CD000978, 2010.
[19] H.V.Worthington, J. E. Clarkson,G. Bryan et al., “Interventions
for preventing oral mucositis for patients with cancer receiving
treatment,” Cochrane Database of Systematic Reviews, vol. 4, p.
CD000978, 2011.
[20] E. Ernst and B. R. Cassileth, “The prevalence of comple-
mentary/alternative medicine in cancer: a systematic review,”
Cancer, vol. 83, no. 4, pp. 777–782, 1998.
[21] H. Boon, J. B. Brown, A. Gavin, M. A. Kennard, and M.
Stewart, “Breast cancer survivors’ perceptions of complemen-
tary/alternative medicine (CAM): making the decision to use
or not to use,”Qualitative Health Research, vol. 9, no. 5, pp. 639–
653, 1999.
[22] H. A. Tindle, R. B. Davis, R. S. Phillips, and D. M. Eisenberg,
“Trends in use of complementary and alternative medicine
by us adults: 1997–2002,” Alternative Therapies in Health and
Medicine, vol. 11, no. 1, pp. 42–49, 2005.
[23] C. W. H. Chan, A. M. Chang, A. Molassiotis, I. Y. M. Lee, and
G. C. T. Lee, “Oral complications in Chinese cancer patients
undergoing chemotherapy,” Supportive Care in Cancer, vol. 11,
no. 1, pp. 48–55, 2003.
[24] M. Porkert, Klinische Chinesische Pharmakologie, Phainon,
Dinkelscherben, Germany, 2nd edition, 1994.
[25] D. Bensky, S. Clavey, and E. Stoger, Chinese Herbal Medicine:
Materia Medica, Eastland Press, Seattle, Wash, USA, 3rd edi-
tion, 2004.
[26] Chinese Pharmacopoeia Commision, Pharmakocoeia of the
People’ Republic of China, ChinaMedical Science Press, Beijing,
China, 2010.
[27] H. Yu, H. Jin,W. Gong, Z.Wang, and H. Liang, “Pharmacologi-
cal actions of multi-target-directed evodiamine,”Molecules, vol.
18, no. 2, pp. 1826–1843, 2013.
[28] T. L. Xu and J. H. Han, “External application of Evodia
rutaecarpa on Acupoint Yongquan in remaining dental ulcer
after chemotherapy. Zhu Yu waifu yong quam xue ke zhiliao
hualiao hou kouqiang kui yang,”Chinese Journal of Nursing, vol.
41, no. 10, p. 837, 2006.
[29] http://www.shen-nong.com/eng/herbal/hongjingtian.html .
[30] H. X. Li, S. C.W. Sze, Y. Tong, and T. B. Ng, “Production ofTh1-
andTh2-dependent cytokines induced by the Chinesemedicine
herb, Rhodiola algida, on human peripheral blood monocytes,”
Journal of Ethnopharmacology, vol. 123, no. 2, pp. 257–266, 2009.
[31] W. T. Y. Loo, L. Jin, L. W. C. Chow, M. N. B. Cheung, and
M. Wang, “Rhodiola algida improves chemotherapy-induced
oral mucositis in breast cancer patients,” Expert Opinion on
Investigational Drugs, vol. 19, supplement 1, pp. S91–S100, 2010.
[32] http://www.naturalremedy.com/Acacia%20catechu.pdf.
[33] J. Tseng-Crank, S. Sung, Q. Jia et al., “A medicinal plant extract
of scutellaria baicalensis and acacia catechu reduced LPS-
stimulated gene expression in immune cells: a comprehensive
genomic study using QPCR, ELISA, andmicroarray,” Journal of
Dietary Supplements, vol. 7, no. 3, pp. 253–272, 2010.
[34] Y. J. Shi and J. Z. Shan, “Observation on the effect of catechin
from traditional Chinese medicine on oral ulcer induced by
chemotherapy,” Journal of Clinical Nursing, vol. 8, no. 1, p. 47,
2009.
[35] H. X. Chen, X. H. Liang, and L. H. Jiang, “Clinical effect
of Kangfuxin liquid in treatment of recurrent aphtous ulcer,”
China Practical Medicine, no. 3, 2011.
[36] L. M. Wang, Y. M. Lu, J. Yu, D. S. Zhu, and W. X. Chen, “Inhi-
bition of the expression of cytokines on experimental colitis in
mice by kangfuxin,” Chinese Journal of Clinical Pharmacology,
no. 3, 2006.
[37] H. Wang, X. F. Xu, Z. W. Zeng et al., “Rehabilitation drug solu-
tion on prevention and treatment of chemotherapy-induced
oral ulcers,”Medical Information, no. 12, p. 3742, 2010.
[38] J. T.Wu,WenBingTiaoBian (SystematicDifferentiation ofWarm
Diseases), vol. 1798, NanjingUniversity of TCM,WarmDiseases
Department; People’s Medical Publishing House, 2005.
[39] V. Scheid, D. Bensky, A. Ellis, and R. Barolet, Chinese Herbal
Medicine: Formulas and Strategies, Eastland Press , Seattle,
Wash, USA, 2nd edition, 2004.
[40] M. Porkert, Klassische Chinesische Rezeptur, Phainon, Dinkels-
cherben, Germany, 2nd edition, 1994.
[41] Y. Liao, S. Dong, R. Kijama, P. Cai, L. Liu, and H. Shen, “Flos
lonicerae exracts and chlorogenic acid protect human umbilical
vein endothelia cells from the toxic damage of perfluorooctane
sulphonate,” Inflammation, vol. 36, no. 3, pp. 767–779, 2013.
[42] E. M. Shin, H. Y. Zhou, L. Y. Guo et al., “Anti-inflammatory
effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-
stimulated RAW264.7 macrophages,” International Immuno-
pharmacology, vol. 8, no. 11, pp. 1524–1532, 2008.
[43] Y.W. Kim, R. J. Zhao, S. J. Park et al., “Anti-inflammatory effects
of liquiritigenin as a consequence of the inhibition of NF-𝜅B-
dependent iNOS and proinflammatory cytokines production,”
British Journal of Pharmacology, vol. 154, no. 1, pp. 165–173,
2008.
[44] Z. Q. Ma and X. H. Song, “Licorice and Honeysuckle decoction
for prevention oral ulcer by high dose chemotherapy: a clinical
observation. Gan cao Jin Hua jian yin yufang da ji liang hualiao
kouqiang kuiyang de linchuang guancha,” Modern Journal of
Lntegrated Traditional Chinese andWesternMedicine, no. 18, pp.
2408–2409, 2005.
[45] Y. X. Zeng, “Yin Hua Gan Cao decoction was used to treat
stomatitis caused by chemical therapy. Yin Hua Gan Cao Tang
yongyu hualiao bingren kouqiang yan de huli tihui,” Guiding
Journal of TCM, vol. 11, no. 12, pp. 50–51, 2005.
14 Evidence-Based Complementary and Alternative Medicine
[46] A. Nalbantsoy, T. Nesil, O. Yilmaz-Dilsiz, G. Aksu, S. Khan, and
E. Bedir, “Evaluation of the immunomodulatory properties in
mice and in vitro anti-inflammatory activity of cycloartane type
saponins from Astragalus species,” Journal of Ethnopharmacol-
ogy, vol. 139, no. 2, pp. 574–581, 2012.
[47] N. X. Bao, G. Z. Zeng, L. W. Zhou, X. Y. Shu, and L. Yang, “Pre-
ventive effect of self-made gargle solution on chemotherapy-
induced oral ulcer in patients with colorectal carcinoma,”
Journal of Nursing Science, vol. 23, no. 20, pp. 44–45, 2008.
[48] J. Y. Chen, A. L. Peng, G. Z. Hao, H. Zhu, and Y. Z. Yao,
“Curative effect of ophiopogonon tubermixture on ulcer of oral
cavity after chemotherapy. Mai Dong He Ji zhiliao hualiao hou
kouqian kuiyang xiaoguo guancha,” Journal of Nursing Science,
vol. 20, no. 20, pp. 76–77, 2005.
[49] X. E. Wu Zhu YF, Y. M. Lai, and X. H. Xie, “Gargle medicine ice
observation on the effects of chemotherapy in patients with oral
ulcer,” Journal of Nursing, vol. 16, no. 9, pp. 64–65, 2009.
[50] L. H. Wang, A. W. Dai, and L. Wang, “The effect of Sheng-
mai injection on alleviating acute chemotherapy toxicity. Wu
Zhu Yu waifu yongquan xue ke zhiliao hualiao hou kouqian
kuiyang,” New Journal of Traditional Chinese Medicine, vol. 38,
no. 12, pp. 38–39, 2006.
[51] T. Jin, M. H. Shen, Y. F. Sun, and J. Zhang, “Water Grass
Decoction for treating Chemotherapy-induced Oral Ulcers.
Shui Zhong Cao Tang Ji zhiliao hualiao suozhi kouqiang
kuiyang,” Chinese Arcieves of Raditional Chinese Medicine, vol.
27, no. 2, pp. 303–305, 2009.
[52] F. J. Hou, B. C. Jin, and W. Li, “Observation on the effects
of yellow five gargle for oral ulcers caused by chemotherapy.
Huang Wu shukouye yongyu hualiao suoshi kouqiang kuiyang
de xiaoguo guancha,” Journal of Nursing Science, vol. 16, no. 8,
pp. 494–495, 2001.
[53] H. Zhu and J. Zhang, “Treatment of stomatological complica-
tions in 31 cases of acute leukemia with Chinese herbal drugs,”
Journal of Traditional Chinese Medicine, vol. 13, no. 4, pp. 253–
256, 1993.
[54] Z. X. Zhou, Z. R. Zhang, H. X. Qian, Z. Q. Li, W. M. Wu, and J.
Luo, “Traditional Chinese medicine in preventing and treating
oral ulcer induced by chemotherapy clinical observation,”
Journal of Sichuan of Traditional Chinese Medicine, vol. 23, no.
10, pp. 93–94, 2005.
[55] C. Y. Chen andY. Z. Zheng, “Clinical study on prevention of oral
ulcers caused by chemotherapy with the combined therapy of
centrum and specific Chinese herbs that invigorate the function
of the spleen and regulate the flow of Qi,” Chinese Journal of
Clinical Nutrition, vol. 13, no. 6, pp. 398–400, 2005.
[56] J. H. Sun, “Clinical Observation of modified Xiehuang Pow-
der in the Treatment of Oral Ulcer following Chemotherapy.
Xie Huang San jiawei zhiliao hualiao hou kouqiang kuiyang
linchuang guancha,” Modern Journal of Integrated Traditional
Chinese and Western Medicine, vol. 16, no. 7, pp. 900–901, 2007.
[57] A. Wang, Yi Fang Yi Jie (Analytic Collection of Medical Formu-
las), People’s Medical Publishing House, 2006.
[58] X. Wu, H. Dai, L. Huang, X. Gao, K. W. K. Tsim, and P. Tu, “A
fructan, from radix ophiopogonis, stimulates the proliferation
of cultured lymphocytes: structural and functional analyses,”
Journal of Natural Products, vol. 69, no. 9, pp. 1257–1260, 2006.
[59] J. Y. Kim, Y. P. Hwang, D. H. Kim et al., “Inhibitory effect of
the saponins derived from roots of Platycodon grandiflorum on
carrageenan-induced inflammation,” Bioscience, Biotechnology
and Biochemistry, vol. 70, no. 4, pp. 858–864, 2006.
[60] M. S. Cheon, T. Yoon,D. Y. Lee et al., “Chrysanthemum indicum
Linne´ extract inhibits the inflammatory response by sup-
pressing NF-𝜅B and MAPKs activation in lipopolysaccharide-
induced RAW 264.7 macrophages,” Journal of Ethnopharmacol-
ogy, vol. 122, no. 3, pp. 473–477, 2009.
[61] L.-X. Sun, L.-H. Chen, Z.-B. Lin et al., “Effects of Ganoderma
lucidum polysaccharides on IEC-6 cell proliferation, migration
and morphology of differentiation benefiting intestinal epithe-
lium healing in vitro,” Journal of Pharmacy and Pharmacology,
vol. 63, no. 12, pp. 1595–1603, 2011.
[62] L. Tie, H.-Q. Yang, Y. An et al., “Ganoderma lucidum polysac-
charide accelerates refractory wound healing by inhibition
of mitochondrial oxidative stress in type 1 diabetes,” Cellular
Physiology and Biochemistry, vol. 29, no. 3-4, pp. 583–594, 2012.
[63] H. M. Yoon, K. J. Jang, M. S. Han et al., “Ganoderma
lucidum ethanol extract inhibits the inflammatory response
by suppressing the NF-kB and toll-like receptor pathways in
lipopolysaccharide-stimulated BV2 microglial cells,” Experi-
mental andTherapeuticMedicine, vol. 5, no. 3, pp. 957–936, 2013.
[64] R. W. K. Wong, U. Ha¨gg, L. Samaranayake, M. K. Z. Yuen, C.
J. Seneviratne, and R. Kao, “Antimicrobial activity of Chinese
medicine herbs against common bacteria in oral biofilm.A pilot
study,” International Journal of Oral and Maxillofacial Surgery,
vol. 39, no. 6, pp. 599–605, 2010.
[65] B. C. L. Chan, K. L. E. Hon, P. C. Leung et al., “Traditional
Chinese medicine for atopic eczema: penta herbs formula
suppresses inflammatory mediators release from mast cells,”
Journal of Ethnopharmacology, vol. 120, no. 1, pp. 85–91, 2008.
[66] C. A. Migliorati, L. Oberle-Edwards, and M. Schubert, “The
role of alternative and natural agents, cryotherapy, and/or laser
for management of alimentary mucositis,” Supportive Care in
Cancer, vol. 14, no. 6, pp. 533–540, 2006.
[67] Y. S. Zhang, Yu Xue Qi Yuan (Expounding on the Origins of
Medicine): Yuan Dynasty, People’s MilitaryMedical Press, 2002.
[68] D. C. W. Lee and A. S. Y. Lau, “Effects of Panax ginseng
on tumor necrosis factor-𝛼-mediated inflammation: a mini-
review,”Molecules, vol. 16, no. 4, pp. 2802–2816, 2011.
[69] W. K. Kim, S. Y. Song, W. K. Oh et al., “Wound-healing effect
of ginsenoside Rd from leaves of Panax ginseng via cyclic
AMP-dependent protein kinase pathway,” European Journal of
Pharmacology, vol. 702, no. 1–3, pp. 285–293, 2013.
[70] H. Nishida, N. Tatewaki, Y. Nakajima et al., “Inhibition of
ATR protein kinase activity by schisandrin B in DNA damage
response,” Nucleic Acids Research, vol. 37, no. 17, pp. 5678–5689,
2009.
[71] Y. Takimoto, H. Y. Qian, E. Yoshigai, T. Okomura, Y. Ikeya, and
M.Nishizawa, “GomisinN in the herbal drug gomishi (Schisan-
dra chinensis) suppresses inductible nitric oxide synthase gene
via C/EBPbeta and NF-kB in rat hepatocytes,”Nitric Oxide, vol.
28, pp. 47–56, 2013.
[72] R. Liu, M. Wang, and J.-A. Duan, “Antipyretic and antioxidant
activities of the aqueous extract of Cornu Bubali (water buffalo
horn),”TheAmerican Journal of Chinese Medicine, vol. 38, no. 2,
pp. 293–306, 2010.
[73] Y. Tu, L. Sun,M. Guo, andW. Chen, “Themedicinal uses of Cal-
licarpa L. in traditional Chinese medicine: an Ethnopharmaco-
logical, phytochemical and pharmacological review,” Journal of
Ethnopharmacology, vol. 146, no. 2, pp. 465–481, 2013.
[74] D. Y. Li, Lan Shi Mi Cang (Secrets From the Orchid Chamber),
vol. 1336, People’s Medical Publishing House, 2005.
[75] Y.-K. Park, Y. S. Chung, Y. S. Kim, O.-Y. Kwon, and T. H.
Joh, “Inhibition of gene expression and production of iNOS
Evidence-Based Complementary and Alternative Medicine 15
and TNF-𝛼 in LPS-stimulated microglia by methanol extract of
Phellodendri cortex,” International Immunopharmacology, vol.
7, no. 7, pp. 955–962, 2007.
[76] K. Kim, S. Lee, S. Shin et al., “Anti-inflammatory function of
arctiin by inhibiting COX-2 expression via NF-𝜅B pathways,”
Journal of Inflammation, vol. 8, article 16, 2011.
[77] http://www.epharmacognosy.com/2012/08/european-verbena-
herb-ma-bian-cao.html.
[78] E. Speroni, R. Cervellati, S. Costa et al., “Effects of differential
extraction of Verbena officinalis on ratmodels of inflammation,
cicatrization and gastric damage,” Planta Medica, vol. 73, no. 3,
pp. 227–235, 2007.
[79] R. Liu, L. Zhang, X. Lan et al., “Protection by borneol on cor-
tical neurons against oxygen-glucose deprivation/reperfusion:
involvement of anti-oxidation and anti-inflammation through
nuclear transcription factor 𝜅appaB signaling pathway,” Neuro-
science, vol. 176, pp. 408–419, 2011.
[80] J. B. Zhang,Collected Treatise of [Zhang] Jing-Yue: 1624. Jing Yue
Quan Shu, People’s Medical Publishing House, 1997.
[81] H. D. Wang, M. Y. Wang, and X. B. Li, “Evaluation of the
antipyretic activity of Gypsum Fibrosum and its constituents,”
Asian Journal of Traditional Medicines, vol. 4, no. 2, 2009.
[82] C. L. Liu, L. Cheng Ko CH, C. W. Wong et al., “Bioassay-
guided isolation of anti-inflammatory components from the
root of Rehmannia glutinosa and ist underlying mechanism via
inhibition of iNOSpathway,” Journal of Ethnopharmacology, vol.
143, no. 3, pp. 867–875, 2012.
[83] H. J. Lee, H. Li, H. R. Chang, H. Jung, D. Y. Lee, and J. H.
Ryu, “(-)-Nyasol, isolated from Anemarrhena asphodeloides
suppresses neuroinflammatory response through the inhibition
of I-alphaBa degradation in LPS-stimulated BV-2 microglial
cells,” Journal of Enzyme Inhibition andMedicinal Chemistry. In
press.
[84] Y. Zou, J. Meng, W. Chen et al., “Modulation of phenotypic
and functional maturation of murine dendritic cells (DCs) by
purifiedAchyranthes bidentata polysaccharide (ABP),” Interna-
tional Immunopharmacology, vol. 11, no. 8, pp. 1103–1108, 2011.
[85] J. M. Kim, H. A. Jung, J. S. Choi, and N. G. Lee, “Identifi-
cation of anti-inflammatory target genes of Rhizoma coptidis
extract in lipopolysaccharide-stimulated RAW264.7 murine
macrophage-like cells,” Journal of Ethnopharmacology, vol. 130,
no. 2, pp. 354–362, 2010.
[86] D. Schmid, F. Woehs, M. Svoboda, T. Thalhammer, P. Chiba,
and T. Moeslinger, “Aqueous extracts of Cimicifuga racemosa
and phenolcarboxylic constituents inhibit production of proin-
flammatory cytokines in LPS-stimulated human whole blood,”
Canadian Journal of Physiology and Pharmacology, vol. 87, no.
11, pp. 963–972, 2009.
[87] C. S. Yun, Y. G. Choi,M. Y. Jeong, J. H. Lee, and S. Lim, “Moutan
cortex radicis inhibits inflammatory changes og gene expression
in lipopolysaccharide-stimulated gingival fibroblasts,” Journal
of Natural Medicines, vol. 67, no. 3, pp. 576–589, 2012.
[88] H. J. Lee, H. Li, H. R. Chang, H. Jung, D. Y. Lee, and J. H.
Ryu, “(-)-Nyasol, 10 isolated from Anemarrhena asphodeloides
suppresses neuroinflammatory response through the inhibition
of I-alphaBa degradation in LPS-stimulated BV-2 microglial
cells,” Journal of Enzyme Inhibition and Medicinal Chemistry,
vol. 28, no. 5, pp. 954–959, 2013.
[89] Y. Fu, B. Liu, J. Liu et al., “Geniposide, from Gardenia
jasminoides Ellis, inhibits the inflammatory response in the
primary mouse macrophages andmouse models,” International
Immunopharmacology, vol. 14, no. 4, pp. 792–798, 2012.
[90] N. Huang, L. Rizshsky, C. C. Hauck, B. J. Nikolau, P. A. Murphy,
and D. F. Birt, “The inhibition of lipopolysaccharide-induced
macrophage inflammation by 4 compounds in Hypericum
perforatum extract is partially dependent on the activation of
SOCS3,” Phytochemistry, vol. 76, pp. 106–116, 2012.
[91] C. H. Hempen and T. Fischer, Leitfaden Chinesische Phytother-
apie, Elsevier, Amsterdam, Netherlands, 2nd edition, 2006.
[92] J.-P. Guo, J. Pang, X.-W. Wang, Z.-Q. Shen, M. Jin, and J.-W.
Li, “In vitro screening of traditionally used medicinal plants in
China against enteroviruses,”World Journal of Gastroenterology,
vol. 12, no. 25, pp. 4078–4081, 2006.
[93] Q.Wu,Yi Zong Jin Jian (GoldenMirror of theMedical Tradition),
vol. 1742, People’s Medical Publishing House, 2006.
[94] H. Turkez, F. Geyikoglu, A. Tatar, M. S. Keles, and I. Kaplan,
“The effects of some boron compounds against heavymetal tox-
icity in human blood,” Experimental and Toxicologic Pathology,
vol. 64, no. 1-2, pp. 93–101, 2012.
[95] M. Pongsavee, “Effect of borax on immune cell proliferation and
sister chromatid exchange in human chromosomes,” Journal of
Occupational Medicine and Toxicology, vol. 4, no. 1, article 27,
2009.
[96] Y.-K. Lin, Y.-L. Leu, T.-H. Huang et al., “Anti-inflammatory
effects of the extract of indigo naturalis in human neutrophils,”
Journal of Ethnopharmacology, vol. 125, no. 1, pp. 51–58, 2009.
[97] J. Xue, Zheng Ti Lei Yao (Catalogued Essentials For Correcting
the Body), vol. 1529, Hainan International Press of World News,
1995.
[98] Tai Ping Hui Min He Ji Ju, Tai Ping Hui Min He Ji Ju Fang
(Imperial Grace Formulary of the Tai Ping Era), 1107, People’s
Medical Publishing House, 2007.
[99] D. Y. Li, Nei Wai Shang Bian Huo Lun (Clearing Doubts About
Injury From Internal and External Causes), vol. 1247, People’s
Medical Publishing House, 2007.
[100] http://www.tcmassistant.com.
[101] Y. G. Lee, J. Y. Kim, J. Y. Lee et al., “Regulatory effects
of Codonopsis lanceolata on macrophage-mediated immune
responses,” Journal of Ethnopharmacology, vol. 112, no. 1, pp.
180–188, 2007.
[102] S. Kim, S. Shin, B. Hyun et al., “Immunmodulatory effects of
dioscoreae rhizome against inflammation through suppressed
production of cytokines via inhibition of the NF-kappaB path-
way,” Immune Network, vol. 12, no. 5, pp. 181–188, 2012.
[103] C.W. Han,M. J. Kwun, K. H. Kim et al., “Ethanol extract of alis-
matis rhizoma reduces acute lung inflammation by suppressing
NF-kappaB and activatingNrf2,” Journal of Ethnopharmacology,
vol. 146, no. 1, pp. 402–410, 2013.
[104] H. M. Oh, Y. J. Kang, Y. S. Lee et al., “Protein kinase G-
dependent heme oxygenase-1 induction by Agastache rugosa
leaf extract protects RAW264.7 cells from hydrogen peroxide-
induced injury,” Journal of Ethnopharmacology, vol. 103, no. 2,
pp. 229–235, 2006.
[105] Y. Wang, M. Chen, J. Zhang et al., “Flavone C-glycosides from
the leaves of Lophatherum gracile and their in vitro antiviral
activity,” Planta Medica, vol. 78, no. 1, pp. 46–51, 2012.
[106] Y. Qian, Xiao Er Yao Zheng Zhi Jue (Craft of Medicines and
Patterns For Children), vol. 1119, People’s Publishing Medical
House, 2007.
[107] J. Tai and S. Cheung, “Anti-proliferative and antioxidant activi-
ties of Saposhnikovia divaricata,” Oncology Reports, vol. 18, no.
1, pp. 227–234, 2007.
16 Evidence-Based Complementary and Alternative Medicine
[108] X. Zhang, H. Xiong, and L. Liu, “Effects of taraxasterol on
inflammatory responses in lipopolysaccharide- induced RAW
264.7 macrophages,” Journal of Ethnopharmacology, vol. 141, no.
1, pp. 206–211, 2012.
[109] X. Lin, P.-C. Shaw, S. C.-W. Sze, Y. Tong, andY. Zhang, “Dendro-
bium officinale polysaccharides ameliorate the abnormality of
aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis
in the experimental Sjo¨gren’s syndrome mice,” International
Immunopharmacology, vol. 11, no. 12, pp. 2025–2032, 2011.
[110] Y. L. Wei, Shi Yi De Xiao Fang (Effective Formulas From Gen-
erations of Physicians), vol. 1345, Peoples Medical Publishing
House, 2006.
[111] C. L.Wang, “Present situation of study on TCMprevention and
treatment of oral ulcer induced by chemotherapy,” Journal of
Nursing, vol. 18, no. 3, pp. 16–19, 2011.
[112] J. P. Liu, M. Zhang, W. Y. Wang, and S. Grimsgaard, “Chi-
nese herbal medicines for type 2 diabetes mellitus,” Cochrane
Database of Systematic Reviews, no. 3, p. CD003642, 2004.
[113] W. C. S. Cho, “Scientific evidence on the supportive cancer care
with chinese medicine,” Chinese Journal of Lung Cancer, vol. 13,
no. 3, pp. 190–194, 2010.
[114] S.G. Li,H. Y. Chen, C. S.Ou-Yang et al., “The efficacy ofChinese
herbal medicine as an adjunctive therapy, for advanced non-
small cell lung cancer: a systematic review and meta-analysis,”
PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013.
[115] X.-Y. Tian and L. Liu, “Drug discovery enters a new era
with multi-target intervention strategy,” Chinese Journal of
Integrative Medicine, vol. 18, no. 7, pp. 539–542, 2012.
[116] J.- J. Lu, W. Pan, Y.-J. Hu, and Y.-T. Wang, “Multi-target drugs:
the trend of drug research and development,” PLoS ONE, vol. 7,
no. 6, Article ID e40262, 2012.
[117] B. M. Schmidt, D. M. Ribnicky, P. E. Lipsky, and I. Raskin,
“Revisiting the ancient concept of botanical therapeutics,”
Nature Chemical Biology, vol. 3, no. 7, pp. 360–366, 2007.
[118] L. Wu, X. P. Ding, D. N. Zhu, B. Y. Yu, and Y. Q. Yan, “Study
on the radical scavengers in the traditional Chinese medicine
formula Shengmai San by HPLC-DAD coupled with chemilu-
minescence (CL) and ESI-MS/MS,” Journal of Pharmaceutical
and Biomedical Analysis, vol. 52, no. 4, pp. 438–445, 2010.
[119] Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei,
“Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine,
in streptozotocin-induced diabetic mice,” Japanese Journal of
Pharmacology, vol. 79, no. 2, pp. 169–175, 1999.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
International Journal of
Endocrinology
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
BioMed Research 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
PPAR
Resea rch
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Parkinson’s Disease
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
